Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO29659 | Myristicae semen | NA | NA | NA | TCMSP* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | Ki | = | 55 | nM | 2539480 |
NPT289 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Rattus norvegicus | Ki | = | 17 | nM | 2539480 |
NPT1776 | Protein Family | Serotonin 1 (5-HT1) receptor | Rattus norvegicus | Ki | = | 300 | nM | 3543362 |
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | Ki | = | 115 | nM | 3543362 |
NPT289 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Rattus norvegicus | Ki | = | 50 | nM | 3543362 |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | Ki | = | 1400 | nM | 3543362 |
NPT1777 | Protein Family | Serotonin 2 (5-HT2) receptor | Rattus norvegicus | Ki | = | 3500 | nM | 3543362 |
NPT1777 | Protein Family | Serotonin 2 (5-HT2) receptor | Rattus norvegicus | Ki | = | 5900 | nM | 3543362 |
NPT973 | Individual Protein | Serotonin 1b (5-HT1b) receptor | Homo sapiens | Ki | = | 4100 | nM | 9435911 |
NPT1774 | Protein Family | Sodium channel alpha subunits; brain (Types I, II, III) | Homo sapiens | IC50 | = | 13000 | nM | 2579237 |
NPT1774 | Protein Family | Sodium channel alpha subunits; brain (Types I, II, III) | Homo sapiens | Inhibition | = | 42.6 | % | 2579237 |
NPT4333 | Protein Family | Adrenergic receptor beta | Rattus norvegicus | Kd | = | 0.7 | nM | 6120233 |
NPT2859 | Individual Protein | Cytochrome P450 2D1 | Rattus norvegicus | IC50 | = | 571000 | nM | 12502361 |
NPT2860 | Individual Protein | Cytochrome P450 2D2 | Rattus norvegicus | IC50 | = | 350 | nM | 12502361 |
NPT2861 | Individual Protein | Cytochrome P450 2D3 | Rattus norvegicus | IC50 | = | 172000 | nM | 12502361 |
NPT2862 | Individual Protein | Cytochrome P450 2D18 | Rattus norvegicus | IC50 | = | 133000 | nM | 12502361 |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | IC50 | = | 1400 | nM | 12502361 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 574000 | nM | 12477351 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Ki | = | 170000 | nM | 12477351 |
NPT1778 | Individual Protein | Serotonin 2a (5-HT2a) receptor | Rattus norvegicus | Ki | = | 8100 | nM | 9214741 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | EC50 | = | 1.8 | nM | 16562853 |
NPT2 | Others | Unspecified | Inhibition | = | 26 | % | 18182301 | |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | AC50 | = | 2511.89 | nM | PubChem BioAssay data set |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | AC50 | = | 199.53 | nM | PubChem BioAssay data set |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 6701.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 14575 | nM | PubChem BioAssay data set | ||
NPT699 | Individual Protein | UDP-glucuronosyltransferase 1-10 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT695 | Individual Protein | UDP-glucuronosyltransferase 1-8 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 1.908 | nM | DrugMatrix in vitro pharmacology data |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 1.102 | nM | DrugMatrix in vitro pharmacology data |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | IC50 | = | 0.355 | nM | DrugMatrix in vitro pharmacology data |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 0.244 | nM | DrugMatrix in vitro pharmacology data |
NPT227 | Individual Protein | Beta-3 adrenergic receptor | Homo sapiens | IC50 | = | 165 | nM | DrugMatrix in vitro pharmacology data |
NPT227 | Individual Protein | Beta-3 adrenergic receptor | Homo sapiens | Ki | = | 124 | nM | DrugMatrix in vitro pharmacology data |
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | IC50 | = | 124 | nM | DrugMatrix in vitro pharmacology data |
NPT288 | Individual Protein | Serotonin 1a (5-HT1a) receptor | Rattus norvegicus | Ki | = | 71 | nM | DrugMatrix in vitro pharmacology data |
NPT290 | Individual Protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | IC50 | = | 1883 | nM | DrugMatrix in vitro pharmacology data |
NPT290 | Individual Protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | Ki | = | 538 | nM | DrugMatrix in vitro pharmacology data |
NPT291 | Individual Protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | IC50 | = | 411 | nM | DrugMatrix in vitro pharmacology data |
NPT291 | Individual Protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | Ki | = | 262 | nM | DrugMatrix in vitro pharmacology data |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | IC50 | = | 1368 | nM | DrugMatrix in vitro pharmacology data |
NPT292 | Individual Protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | Ki | = | 716 | nM | DrugMatrix in vitro pharmacology data |
NPT294 | Individual Protein | Serotonin 6 (5-HT6) receptor | Homo sapiens | IC50 | = | 998 | nM | DrugMatrix in vitro pharmacology data |
NPT294 | Individual Protein | Serotonin 6 (5-HT6) receptor | Homo sapiens | Ki | = | 463 | nM | DrugMatrix in vitro pharmacology data |
NPT295 | Individual Protein | Serotonin transporter | Homo sapiens | IC50 | = | 1241 | nM | DrugMatrix in vitro pharmacology data |
NPT295 | Individual Protein | Serotonin transporter | Homo sapiens | Ki | = | 659 | nM | DrugMatrix in vitro pharmacology data |
NPT296 | Individual Protein | Sigma opioid receptor | Homo sapiens | IC50 | = | 6665 | nM | DrugMatrix in vitro pharmacology data |
NPT296 | Individual Protein | Sigma opioid receptor | Homo sapiens | Ki | = | 2801 | nM | DrugMatrix in vitro pharmacology data |
NPT748 | Individual Protein | Bile acid transporter | Homo sapiens | IC50 | = | 6100 | nM | 10565843 |
NPT2 | Others | Unspecified | Potency | 26608.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33498.3 | nM | PubChem BioAssay data set | ||
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Inhibition | = | -5 | % | 23403082 |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Ki | = | 0.54 | nM | 23403082 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | Ki | = | 1.4 | nM | 23403082 |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | IC50 | = | 0.78 | nM | 23403082 |
NPT225 | Individual Protein | Beta-1 adrenergic receptor | Homo sapiens | IC50 | = | 2.5 | nM | 23403082 |
NPT226 | Individual Protein | Beta-2 adrenergic receptor | Homo sapiens | Inhibition | = | 8 | % | 23403082 |
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | 37933 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 25118.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6309.6 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC231163 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC318591 |
0.9147 | High Similarity | NPC141739 |
0.9147 | High Similarity | NPC136112 |
0.8855 | High Similarity | NPC320242 |
0.8467 | Intermediate Similarity | NPC307123 |
0.8467 | Intermediate Similarity | NPC97870 |
0.8467 | Intermediate Similarity | NPC247018 |
0.7883 | Intermediate Similarity | NPC328267 |
0.7877 | Intermediate Similarity | NPC204546 |
0.7843 | Intermediate Similarity | NPC477564 |
0.7843 | Intermediate Similarity | NPC2295 |
0.7597 | Intermediate Similarity | NPC76213 |
0.7597 | Intermediate Similarity | NPC277669 |
0.7582 | Intermediate Similarity | NPC207824 |
0.7582 | Intermediate Similarity | NPC60538 |
0.7574 | Intermediate Similarity | NPC329980 |
0.7516 | Intermediate Similarity | NPC29647 |
0.75 | Intermediate Similarity | NPC124433 |
0.75 | Intermediate Similarity | NPC293871 |
0.7482 | Intermediate Similarity | NPC211992 |
0.7468 | Intermediate Similarity | NPC79328 |
0.7468 | Intermediate Similarity | NPC477565 |
0.7468 | Intermediate Similarity | NPC103379 |
0.7463 | Intermediate Similarity | NPC26524 |
0.7451 | Intermediate Similarity | NPC476151 |
0.7432 | Intermediate Similarity | NPC253429 |
0.7429 | Intermediate Similarity | NPC71090 |
0.7429 | Intermediate Similarity | NPC298486 |
0.7407 | Intermediate Similarity | NPC476573 |
0.7407 | Intermediate Similarity | NPC470837 |
0.7407 | Intermediate Similarity | NPC35627 |
0.7407 | Intermediate Similarity | NPC195392 |
0.7407 | Intermediate Similarity | NPC81247 |
0.7405 | Intermediate Similarity | NPC203784 |
0.7405 | Intermediate Similarity | NPC194034 |
0.7405 | Intermediate Similarity | NPC126519 |
0.7405 | Intermediate Similarity | NPC170503 |
0.7376 | Intermediate Similarity | NPC217277 |
0.7368 | Intermediate Similarity | NPC294249 |
0.7357 | Intermediate Similarity | NPC290451 |
0.7357 | Intermediate Similarity | NPC127389 |
0.7349 | Intermediate Similarity | NPC329969 |
0.7338 | Intermediate Similarity | NPC321133 |
0.7333 | Intermediate Similarity | NPC477837 |
0.7333 | Intermediate Similarity | NPC477838 |
0.7324 | Intermediate Similarity | NPC293701 |
0.7324 | Intermediate Similarity | NPC114901 |
0.7324 | Intermediate Similarity | NPC109822 |
0.7324 | Intermediate Similarity | NPC48990 |
0.7324 | Intermediate Similarity | NPC94276 |
0.7313 | Intermediate Similarity | NPC21890 |
0.7305 | Intermediate Similarity | NPC188997 |
0.7299 | Intermediate Similarity | NPC290470 |
0.7299 | Intermediate Similarity | NPC154256 |
0.7296 | Intermediate Similarity | NPC160931 |
0.7296 | Intermediate Similarity | NPC37205 |
0.7286 | Intermediate Similarity | NPC473875 |
0.7286 | Intermediate Similarity | NPC212559 |
0.7285 | Intermediate Similarity | NPC323204 |
0.7283 | Intermediate Similarity | NPC475754 |
0.7279 | Intermediate Similarity | NPC160692 |
0.7273 | Intermediate Similarity | NPC194519 |
0.7267 | Intermediate Similarity | NPC158900 |
0.726 | Intermediate Similarity | NPC326599 |
0.726 | Intermediate Similarity | NPC329595 |
0.7254 | Intermediate Similarity | NPC255253 |
0.7254 | Intermediate Similarity | NPC474130 |
0.7254 | Intermediate Similarity | NPC261992 |
0.725 | Intermediate Similarity | NPC129603 |
0.7246 | Intermediate Similarity | NPC137096 |
0.7239 | Intermediate Similarity | NPC209377 |
0.7233 | Intermediate Similarity | NPC204828 |
0.7233 | Intermediate Similarity | NPC276588 |
0.7233 | Intermediate Similarity | NPC54379 |
0.7233 | Intermediate Similarity | NPC39701 |
0.7233 | Intermediate Similarity | NPC278799 |
0.7233 | Intermediate Similarity | NPC207757 |
0.7233 | Intermediate Similarity | NPC172765 |
0.7233 | Intermediate Similarity | NPC249797 |
0.7233 | Intermediate Similarity | NPC110416 |
0.7233 | Intermediate Similarity | NPC2413 |
0.7233 | Intermediate Similarity | NPC469817 |
0.7233 | Intermediate Similarity | NPC193949 |
0.7233 | Intermediate Similarity | NPC189266 |
0.7233 | Intermediate Similarity | NPC295691 |
0.7233 | Intermediate Similarity | NPC184026 |
0.7233 | Intermediate Similarity | NPC127674 |
0.7233 | Intermediate Similarity | NPC5238 |
0.7229 | Intermediate Similarity | NPC475215 |
0.7229 | Intermediate Similarity | NPC108434 |
0.7226 | Intermediate Similarity | NPC106295 |
0.7226 | Intermediate Similarity | NPC321505 |
0.7226 | Intermediate Similarity | NPC283169 |
0.7226 | Intermediate Similarity | NPC191376 |
0.7226 | Intermediate Similarity | NPC51957 |
0.7226 | Intermediate Similarity | NPC210437 |
0.7226 | Intermediate Similarity | NPC16107 |
0.7226 | Intermediate Similarity | NPC179825 |
0.7226 | Intermediate Similarity | NPC476144 |
0.7222 | Intermediate Similarity | NPC191037 |
0.7222 | Intermediate Similarity | NPC58607 |
0.7222 | Intermediate Similarity | NPC178284 |
0.7219 | Intermediate Similarity | NPC314682 |
0.7219 | Intermediate Similarity | NPC83289 |
0.7219 | Intermediate Similarity | NPC189724 |
0.7219 | Intermediate Similarity | NPC212850 |
0.7215 | Intermediate Similarity | NPC206372 |
0.7215 | Intermediate Similarity | NPC114124 |
0.7215 | Intermediate Similarity | NPC203424 |
0.7214 | Intermediate Similarity | NPC263835 |
0.7211 | Intermediate Similarity | NPC118419 |
0.7211 | Intermediate Similarity | NPC284232 |
0.7208 | Intermediate Similarity | NPC185838 |
0.7205 | Intermediate Similarity | NPC7393 |
0.7203 | Intermediate Similarity | NPC61685 |
0.72 | Intermediate Similarity | NPC193528 |
0.72 | Intermediate Similarity | NPC14600 |
0.72 | Intermediate Similarity | NPC41473 |
0.72 | Intermediate Similarity | NPC204848 |
0.72 | Intermediate Similarity | NPC160607 |
0.72 | Intermediate Similarity | NPC312770 |
0.7195 | Intermediate Similarity | NPC56887 |
0.7195 | Intermediate Similarity | NPC124657 |
0.7195 | Intermediate Similarity | NPC223077 |
0.7195 | Intermediate Similarity | NPC193853 |
0.7194 | Intermediate Similarity | NPC474040 |
0.7194 | Intermediate Similarity | NPC474214 |
0.7194 | Intermediate Similarity | NPC283616 |
0.7188 | Intermediate Similarity | NPC180756 |
0.7188 | Intermediate Similarity | NPC323443 |
0.7186 | Intermediate Similarity | NPC66341 |
0.7186 | Intermediate Similarity | NPC192135 |
0.7186 | Intermediate Similarity | NPC477020 |
0.7183 | Intermediate Similarity | NPC46586 |
0.7183 | Intermediate Similarity | NPC204535 |
0.7183 | Intermediate Similarity | NPC152946 |
0.7181 | Intermediate Similarity | NPC141023 |
0.7181 | Intermediate Similarity | NPC478085 |
0.7179 | Intermediate Similarity | NPC476571 |
0.7179 | Intermediate Similarity | NPC24233 |
0.7179 | Intermediate Similarity | NPC147390 |
0.7179 | Intermediate Similarity | NPC7467 |
0.7179 | Intermediate Similarity | NPC428 |
0.7179 | Intermediate Similarity | NPC135538 |
0.7179 | Intermediate Similarity | NPC246587 |
0.7178 | Intermediate Similarity | NPC233650 |
0.7178 | Intermediate Similarity | NPC475393 |
0.7176 | Intermediate Similarity | NPC241224 |
0.7172 | Intermediate Similarity | NPC111247 |
0.7172 | Intermediate Similarity | NPC183181 |
0.7172 | Intermediate Similarity | NPC147821 |
0.7172 | Intermediate Similarity | NPC319625 |
0.7172 | Intermediate Similarity | NPC292056 |
0.7172 | Intermediate Similarity | NPC163332 |
0.7172 | Intermediate Similarity | NPC118787 |
0.7172 | Intermediate Similarity | NPC469386 |
0.7172 | Intermediate Similarity | NPC41706 |
0.7172 | Intermediate Similarity | NPC474119 |
0.7171 | Intermediate Similarity | NPC474915 |
0.7171 | Intermediate Similarity | NPC213206 |
0.7171 | Intermediate Similarity | NPC328750 |
0.7171 | Intermediate Similarity | NPC188163 |
0.717 | Intermediate Similarity | NPC475557 |
0.717 | Intermediate Similarity | NPC233926 |
0.7169 | Intermediate Similarity | NPC477562 |
0.7169 | Intermediate Similarity | NPC26240 |
0.7169 | Intermediate Similarity | NPC69712 |
0.7163 | Intermediate Similarity | NPC207613 |
0.7162 | Intermediate Similarity | NPC230219 |
0.7162 | Intermediate Similarity | NPC189482 |
0.7161 | Intermediate Similarity | NPC473934 |
0.716 | Intermediate Similarity | NPC18402 |
0.7152 | Intermediate Similarity | NPC210140 |
0.7143 | Intermediate Similarity | NPC78359 |
0.7143 | Intermediate Similarity | NPC186469 |
0.7143 | Intermediate Similarity | NPC315707 |
0.7143 | Intermediate Similarity | NPC163036 |
0.7143 | Intermediate Similarity | NPC148014 |
0.7143 | Intermediate Similarity | NPC40389 |
0.7143 | Intermediate Similarity | NPC256369 |
0.7143 | Intermediate Similarity | NPC11089 |
0.7143 | Intermediate Similarity | NPC143483 |
0.7143 | Intermediate Similarity | NPC474320 |
0.7143 | Intermediate Similarity | NPC65490 |
0.7135 | Intermediate Similarity | NPC476575 |
0.7134 | Intermediate Similarity | NPC169743 |
0.7134 | Intermediate Similarity | NPC134858 |
0.7133 | Intermediate Similarity | NPC140359 |
0.7133 | Intermediate Similarity | NPC13020 |
0.7132 | Intermediate Similarity | NPC165646 |
0.7125 | Intermediate Similarity | NPC150670 |
0.7122 | Intermediate Similarity | NPC120075 |
0.7122 | Intermediate Similarity | NPC86947 |
0.7121 | Intermediate Similarity | NPC470393 |
0.7118 | Intermediate Similarity | NPC267408 |
0.7114 | Intermediate Similarity | NPC263064 |
0.7114 | Intermediate Similarity | NPC475840 |
0.7114 | Intermediate Similarity | NPC26394 |
0.7114 | Intermediate Similarity | NPC138940 |
0.7113 | Intermediate Similarity | NPC343720 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC231163 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD2156 | Approved |
1.0 | High Similarity | NPD2155 | Approved |
1.0 | High Similarity | NPD2154 | Approved |
0.9389 | High Similarity | NPD3597 | Clinical (unspecified phase) |
0.9147 | High Similarity | NPD1794 | Approved |
0.913 | High Similarity | NPD2677 | Approved |
0.8881 | High Similarity | NPD3162 | Approved |
0.8881 | High Similarity | NPD3163 | Approved |
0.8857 | High Similarity | NPD5160 | Discontinued |
0.8855 | High Similarity | NPD1820 | Approved |
0.8855 | High Similarity | NPD1818 | Approved |
0.8855 | High Similarity | NPD1817 | Approved |
0.8855 | High Similarity | NPD1819 | Approved |
0.8806 | High Similarity | NPD1336 | Approved |
0.8731 | High Similarity | NPD3165 | Approved |
0.8731 | High Similarity | NPD3164 | Approved |
0.8731 | High Similarity | NPD3167 | Approved |
0.8731 | High Similarity | NPD3166 | Approved |
0.869 | High Similarity | NPD2649 | Approved |
0.869 | High Similarity | NPD2651 | Approved |
0.8611 | High Similarity | NPD2676 | Approved |
0.8611 | High Similarity | NPD2675 | Approved |
0.8593 | High Similarity | NPD3179 | Approved |
0.8593 | High Similarity | NPD3180 | Approved |
0.8582 | High Similarity | NPD4162 | Approved |
0.8529 | High Similarity | NPD3056 | Clinical (unspecified phase) |
0.8478 | Intermediate Similarity | NPD1341 | Clinical (unspecified phase) |
0.8472 | Intermediate Similarity | NPD1774 | Approved |
0.8467 | Intermediate Similarity | NPD1423 | Approved |
0.8451 | Intermediate Similarity | NPD5062 | Approved |
0.8451 | Intermediate Similarity | NPD5061 | Approved |
0.8397 | Intermediate Similarity | NPD2556 | Approved |
0.8397 | Intermediate Similarity | NPD2554 | Approved |
0.8345 | Intermediate Similarity | NPD6087 | Phase 1 |
0.8301 | Intermediate Similarity | NPD4666 | Phase 3 |
0.8286 | Intermediate Similarity | NPD3054 | Approved |
0.8286 | Intermediate Similarity | NPD3052 | Approved |
0.8252 | Intermediate Similarity | NPD1372 | Clinical (unspecified phase) |
0.8239 | Intermediate Similarity | NPD2240 | Approved |
0.8239 | Intermediate Similarity | NPD2239 | Approved |
0.8235 | Intermediate Similarity | NPD5709 | Phase 3 |
0.8224 | Intermediate Similarity | NPD4581 | Clinical (unspecified phase) |
0.8201 | Intermediate Similarity | NPD3530 | Approved |
0.8201 | Intermediate Similarity | NPD3531 | Approved |
0.8201 | Intermediate Similarity | NPD3532 | Approved |
0.8182 | Intermediate Similarity | NPD3049 | Approved |
0.8163 | Intermediate Similarity | NPD4661 | Approved |
0.8163 | Intermediate Similarity | NPD4662 | Approved |
0.8117 | Intermediate Similarity | NPD6315 | Phase 2 |
0.8112 | Intermediate Similarity | NPD3175 | Clinical (unspecified phase) |
0.8108 | Intermediate Similarity | NPD2236 | Approved |
0.8074 | Intermediate Similarity | NPD2235 | Phase 2 |
0.8074 | Intermediate Similarity | NPD2231 | Phase 2 |
0.8071 | Intermediate Similarity | NPD4474 | Approved |
0.8071 | Intermediate Similarity | NPD4475 | Approved |
0.8045 | Intermediate Similarity | NPD1797 | Approved |
0.8045 | Intermediate Similarity | NPD3443 | Approved |
0.8045 | Intermediate Similarity | NPD3444 | Approved |
0.8045 | Intermediate Similarity | NPD3445 | Approved |
0.8045 | Intermediate Similarity | NPD1798 | Approved |
0.8041 | Intermediate Similarity | NPD3985 | Discontinued |
0.8041 | Intermediate Similarity | NPD3536 | Discontinued |
0.8029 | Intermediate Similarity | NPD1770 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD6620 | Discovery |
0.7986 | Intermediate Similarity | NPD6032 | Approved |
0.7945 | Intermediate Similarity | NPD3060 | Approved |
0.7945 | Intermediate Similarity | NPD1416 | Approved |
0.7929 | Intermediate Similarity | NPD6179 | Discontinued |
0.7929 | Intermediate Similarity | NPD5163 | Phase 2 |
0.7905 | Intermediate Similarity | NPD3122 | Phase 3 |
0.7883 | Intermediate Similarity | NPD2429 | Approved |
0.7883 | Intermediate Similarity | NPD2428 | Approved |
0.7879 | Intermediate Similarity | NPD2557 | Approved |
0.7843 | Intermediate Similarity | NPD6677 | Suspended |
0.7838 | Intermediate Similarity | NPD5241 | Discontinued |
0.7812 | Intermediate Similarity | NPD5880 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD5722 | Discontinued |
0.7786 | Intermediate Similarity | NPD5266 | Clinical (unspecified phase) |
0.7718 | Intermediate Similarity | NPD3692 | Discontinued |
0.7714 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7703 | Intermediate Similarity | NPD4237 | Approved |
0.7703 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7697 | Intermediate Similarity | NPD2901 | Approved |
0.7697 | Intermediate Similarity | NPD5976 | Discontinued |
0.7697 | Intermediate Similarity | NPD2900 | Approved |
0.7697 | Intermediate Similarity | NPD6030 | Approved |
0.7697 | Intermediate Similarity | NPD6031 | Approved |
0.7687 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7681 | Intermediate Similarity | NPD2233 | Approved |
0.7681 | Intermediate Similarity | NPD2230 | Approved |
0.7681 | Intermediate Similarity | NPD2232 | Approved |
0.7669 | Intermediate Similarity | NPD595 | Approved |
0.7669 | Intermediate Similarity | NPD593 | Approved |
0.766 | Intermediate Similarity | NPD2250 | Discontinued |
0.7654 | Intermediate Similarity | NPD2163 | Approved |
0.764 | Intermediate Similarity | NPD4575 | Clinical (unspecified phase) |
0.7635 | Intermediate Similarity | NPD2897 | Discontinued |
0.7632 | Intermediate Similarity | NPD3647 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD3465 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD2977 | Approved |
0.7628 | Intermediate Similarity | NPD2978 | Approved |
0.7612 | Intermediate Similarity | NPD709 | Approved |
0.7607 | Intermediate Similarity | NPD42 | Phase 2 |
0.7607 | Intermediate Similarity | NPD3933 | Discontinued |
0.7607 | Intermediate Similarity | NPD6042 | Phase 2 |
0.7607 | Intermediate Similarity | NPD5096 | Phase 3 |
0.7607 | Intermediate Similarity | NPD5095 | Phase 3 |
0.7606 | Intermediate Similarity | NPD596 | Approved |
0.7606 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD600 | Approved |
0.7594 | Intermediate Similarity | NPD592 | Approved |
0.7594 | Intermediate Similarity | NPD594 | Approved |
0.7593 | Intermediate Similarity | NPD5938 | Phase 3 |
0.7584 | Intermediate Similarity | NPD2460 | Phase 3 |
0.7584 | Intermediate Similarity | NPD2458 | Approved |
0.7584 | Intermediate Similarity | NPD2459 | Approved |
0.7584 | Intermediate Similarity | NPD2976 | Clinical (unspecified phase) |
0.7568 | Intermediate Similarity | NPD5865 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD6419 | Discontinued |
0.7566 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7564 | Intermediate Similarity | NPD4018 | Clinical (unspecified phase) |
0.7554 | Intermediate Similarity | NPD2561 | Approved |
0.7554 | Intermediate Similarity | NPD2562 | Approved |
0.7551 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.7551 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7517 | Intermediate Similarity | NPD7037 | Approved |
0.7516 | Intermediate Similarity | NPD7527 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD7526 | Approved |
0.7516 | Intermediate Similarity | NPD6090 | Discontinued |
0.7516 | Intermediate Similarity | NPD52 | Approved |
0.7516 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1102 | Approved |
0.75 | Intermediate Similarity | NPD6582 | Phase 2 |
0.75 | Intermediate Similarity | NPD1103 | Approved |
0.75 | Intermediate Similarity | NPD6583 | Phase 3 |
0.75 | Intermediate Similarity | NPD6812 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6072 | Discontinued |
0.7465 | Intermediate Similarity | NPD558 | Phase 2 |
0.7448 | Intermediate Similarity | NPD2245 | Discovery |
0.7445 | Intermediate Similarity | NPD6580 | Approved |
0.7445 | Intermediate Similarity | NPD6581 | Approved |
0.7445 | Intermediate Similarity | NPD2486 | Discontinued |
0.7419 | Intermediate Similarity | NPD3686 | Approved |
0.7419 | Intermediate Similarity | NPD3687 | Approved |
0.7417 | Intermediate Similarity | NPD3977 | Clinical (unspecified phase) |
0.7415 | Intermediate Similarity | NPD4579 | Clinical (unspecified phase) |
0.7413 | Intermediate Similarity | NPD1712 | Approved |
0.7413 | Intermediate Similarity | NPD2407 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD290 | Approved |
0.7397 | Intermediate Similarity | NPD5837 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD4098 | Discontinued |
0.7391 | Intermediate Similarity | NPD2594 | Approved |
0.7391 | Intermediate Similarity | NPD2595 | Approved |
0.7391 | Intermediate Similarity | NPD6830 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD3156 | Discontinued |
0.7383 | Intermediate Similarity | NPD4476 | Approved |
0.7383 | Intermediate Similarity | NPD4477 | Approved |
0.7379 | Intermediate Similarity | NPD3374 | Clinical (unspecified phase) |
0.7376 | Intermediate Similarity | NPD1669 | Approved |
0.7365 | Intermediate Similarity | NPD5689 | Approved |
0.7365 | Intermediate Similarity | NPD5688 | Approved |
0.7355 | Intermediate Similarity | NPD3033 | Phase 2 |
0.7351 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7348 | Intermediate Similarity | NPD2684 | Approved |
0.7343 | Intermediate Similarity | NPD3690 | Phase 2 |
0.7343 | Intermediate Similarity | NPD3691 | Phase 2 |
0.7338 | Intermediate Similarity | NPD2505 | Approved |
0.7338 | Intermediate Similarity | NPD2423 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD2667 | Approved |
0.7338 | Intermediate Similarity | NPD2504 | Approved |
0.7338 | Intermediate Similarity | NPD2668 | Approved |
0.7338 | Intermediate Similarity | NPD2874 | Phase 2 |
0.7333 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7329 | Intermediate Similarity | NPD6407 | Approved |
0.7329 | Intermediate Similarity | NPD6405 | Approved |
0.732 | Intermediate Similarity | NPD6666 | Approved |
0.732 | Intermediate Similarity | NPD6667 | Approved |
0.7319 | Intermediate Similarity | NPD316 | Approved |
0.7315 | Intermediate Similarity | NPD2661 | Clinical (unspecified phase) |
0.7315 | Intermediate Similarity | NPD1753 | Discontinued |
0.7312 | Intermediate Similarity | NPD3075 | Approved |
0.731 | Intermediate Similarity | NPD1024 | Discontinued |
0.7301 | Intermediate Similarity | NPD3051 | Approved |
0.7297 | Intermediate Similarity | NPD2568 | Approved |
0.7297 | Intermediate Similarity | NPD2989 | Phase 2 |
0.7297 | Intermediate Similarity | NPD2986 | Phase 2 |
0.7292 | Intermediate Similarity | NPD2237 | Approved |
0.729 | Intermediate Similarity | NPD1975 | Clinical (unspecified phase) |
0.7286 | Intermediate Similarity | NPD3294 | Phase 2 |
0.7285 | Intermediate Similarity | NPD1391 | Approved |
0.7279 | Intermediate Similarity | NPD3061 | Approved |
0.7279 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7279 | Intermediate Similarity | NPD3059 | Approved |
0.7279 | Intermediate Similarity | NPD3062 | Approved |
0.7278 | Intermediate Similarity | NPD4773 | Phase 2 |
0.7278 | Intermediate Similarity | NPD4772 | Phase 2 |
0.7273 | Intermediate Similarity | NPD3053 | Approved |
0.7273 | Intermediate Similarity | NPD3055 | Approved |
0.7267 | Intermediate Similarity | NPD8070 | Approved |
PubChem CID   | 91536 |
ChEMBL   | CHEMBL452861 |
ZINC   |
Molecular Weight:   | 259.16 |
ALogP:   | -1.0098 |
MLogP:   | 2.89 |
XLogP:   | 4.053 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 41.49 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 19 |